Phoenix Biosolutions officially announces its launch. The new company was founded by the team who turned microalgae biotechnology into a key industry. (This team has a history of success, as seen with companies like AlgaEnergy). Crucially, it introduces a disruptive Phoenix Biosolutions TaaS (Tech as a Service) model that redefines access to agricultural innovation.

Understanding the Phoenix Biosolutions TaaS Model

Unlike the traditional product-based model, this TaaS approach puts technology directly in the hands of distributors and farmers.

“At Phoenix, we believe that the future of agriculture lies not only in innovation, but in access to it,” says Carlos Rodríguez-Villa Förster, CEO of Phoenix Biosolutions. “Our mission is to democratize biotechnology. We do this by transferring our know-how so producers can manufacture their own biostimulants locally, in a more affordable and sustainable way.”

How the “Tech as a Service” Model Works

Phoenix Biosolutions specializes in establishing turnkey facilities for the production of microalgae-based biostimulants. Furthermore, it works closely with distributors, cooperatives, and large agricultural operations. The Phoenix Biosolutions TaaS model enables:

• Empowering distributors with greater margins and commercial autonomy.
• Providing farmers with access to cutting-edge solutions tailored to their needs.
• Shortening the supply chain, which makes sustainability more scalable.

“Phoenix is not a product company. Instead, it is a technology partner,” adds Rodríguez-Villa. “We are proud to lead a new path that returns control, value, and impact to those who grow our food.”

Market Growth and Global Launch

The agricultural biostimulants market is around EUR 5 billion. Furthermore, experts expect it to grow by 10–12 percent annually in the coming years. This rapid growth is driven by the global demand for sustainable food production and high-efficacy biostimulants. The Phoenix Biosolutions TaaS model is timed perfectly to capitalize on this expanding market by offering a scalable, local production alternative.

Headquartered in Madrid, Phoenix Biosolutions begins operations in Europe and Latin America, with plans for global expansion in the coming months.

Press contact:

Phoenix Biosolutions, Avenida de Europa 16, 28108, Alcobendas, Madrid, Spain • info@phoenixbiosolutions.com • (+34) 911 890 500 • www.phoenixbiosolutions.com